Loading stock…

CRH plc (CRH) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

CRHCRH

Revenue FY25$35.6B

GROWTH RATING↗

WEAK19 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+5%5

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+6%5

EPS growth, FY27E+1%4

EPS growth, FY28E+37%9

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 2%/yr).

WATCH

Revenue grew 5%/yr over the last 3 years and is set to keep growing around 2%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 81% of companies worldwide.

Revenue is set to grow 2%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

CRHCRH

Total return Current243%

Price return Current182%

MOMENTUM RATING↗

WEAK16 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-21%2

YTD return-34%1

MID & LONG-TERM▾SCORE

% of 52-week high63%2

1-year return-30%2

3-year return+51%6

5-year return+91%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +51% over three years and +91% over five, ahead of 60% of the market.

WATCH

None flagged.

WEAKNESSES

It's down 30% over the past year, now 37% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-21%) and so far this year (-34%).

BOTTOM LINE

Outperformer in a Drawdown

A proven multi-year compounder now in a meaningful pullback well below its 52-week high. This is the classic fork: either a buy-the-dip in an intact uptrend, or the early stage of a trend change. Wait for the short-term slide to stabilise before adding. The one thing to watch: the one-year trend is weak.

04Value

Are you paying a fair price for it?

Stop guessing on CRH. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

CRHCRH

Revenue FY25$35.6B

GROWTH RATING↗

WEAK19 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+5%5

Revenue, next 1Y+5%4

Revenue, next 3Y, CAGR+2%2

Revenue, next 5Y, CAGR+2%2

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+6%5

EPS growth, FY27E+1%4

EPS growth, FY28E+37%9

GROWTH ASSESSMENT

STRENGTHS

Earnings are set to grow in step with sales (EPS about 6%/yr vs revenue 2%/yr).

WATCH

Revenue grew 5%/yr over the last 3 years and is set to keep growing around 2%/yr.

WEAKNESSES

Growth is the weak spot here, trailing 81% of companies worldwide.

Revenue is set to grow 2%/yr over the next 3 years, behind most of the market.3/10

Over five years revenue is set to grow 2%/yr, behind 80% of companies worldwide.2/10

BOTTOM LINE

Stalled Business

Growth is a weak point here. The one thing to watch: forward revenue growth trails the market.

03Price Momentum

Is the market behind it right now?

CRHCRH

Total return Current243%

Price return Current182%

MOMENTUM RATING↗

WEAK16 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-10%2

3-month return-21%2

YTD return-34%1

MID & LONG-TERM▾SCORE

% of 52-week high63%2

1-year return-30%2

3-year return+51%6

5-year return+91%7

MOMENTUM ASSESSMENT

STRENGTHS

Strong long-term results. Long-term holders have seen +51% over three years and +91% over five, ahead of 60% of the market.

WATCH

None flagged.

WEAKNESSES

It's down 30% over the past year, now 37% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-10%), over three months (-21%) and so far this year (-34%).

BOTTOM LINE

Outperformer in a Drawdown

04Value

Are you paying a fair price for it?

Stop guessing on CRH. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

CRH plc

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on CRH. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on CRH. Get the full investment case.

Premium